GlassScriptPhysician profile
Sterling E Braun
NPI 1134652597
$3,343.44
in general payments reported to CMS, 2019-2025
12 companies · $1,722 in 2025
The $1,722 reported for 2025 was more than what 81% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $132 · 2022: $174 · 2024: $1,315 · 2025: $1,722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,237 · Honoraria: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,237.21 |
| Honoraria | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $1,279.40 | 2024-2025 | |
| Abbvie INC. | $553.57 | 2024-2025 | |
| Davol INC. | $545.47 | 2022-2025 | Phasix Mesh, Arista |
| Baxter Healthcare | $317.08 | 2021-2025 | |
| Abbott Laboratories | $149.26 | 2025 | Eterna |
| Polynovo North America LLC | $137.47 | 2025 | Novosorb Btm |
| Axogen | $96.57 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Ethicon US, LLC | $83.89 | 2024 | Stratafix, Dermabond Prineo, Surgicel Nu-Knit |
| Stryker Corporation | $68.49 | 2025 | Na |
| Innovation Technologies INC | $52.77 | 2021 | |
| Tela Bio, INC. | $35.18 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $24.29 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sterling Braun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.